ACIU - AC Immune SA

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 193.16M
Enterprise value 79.74M
Trailing P/E 11.63
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)44.65
Price/book (mrq)1.15
Enterprise value/revenue 20.26
Enterprise value/EBITDA -1.19

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-33.81%
S&P500 52-week change 34.08%
52-week high 33.9000
52-week low 31.6800
50-day moving average 32.1515
200-day moving average 32.4458

Share statistics

Avg vol (3-month) 381.54k
Avg vol (10-day) 375.22k
Shares outstanding 583.62M
Implied shares outstanding 6N/A
Float 832.87M
% held by insiders 153.88%
% held by institutions 118.13%
Shares short (14 May 2023) 4255.95k
Short ratio (14 May 2023) 43.08
Short % of float (14 May 2023) 40.65%
Short % of shares outstanding (14 May 2023) 40.31%
Shares short (prior month 13 Apr 2023) 4273.92k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,768.44%

Management effectiveness

Return on assets (ttm)-21.50%
Return on equity (ttm)-37.82%

Income statement

Revenue (ttm)3.94M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-56.4M
EBITDA -67.82M
Net income avi to common (ttm)-69.42M
Diluted EPS (ttm)-0.9200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)105.43M
Total cash per share (mrq)1.26
Total debt (mrq)2.67M
Total debt/equity (mrq)1.74
Current ratio (mrq)10.39
Book value per share (mrq)1.83

Cash flow statement

Operating cash flow (ttm)-67.23M
Levered free cash flow (ttm)-42.6M